Skip to main content
BIAF logo

BIAF · bioAffinity Technologies, Inc. · Metrics

Track BIAF — free
$1.76 -0.09 (-4.86%)
Market Cap
$3.37M
Shares
1.82M
Volume · Nov 20 16.51K Avg daily vol (63 sessions) 3.6M

BIAF metrics

68 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.85
Market cap
$3.37M

Price action

23 metrics
Price change (1W)
-20.9%
Price change (30D)
-48.2%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$71.10
52-week low
$1.85
Change from 52-week high
-97.4%
Change from 52-week low
+0.0%
Annualized volatility
256.2%
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
33.0
Price vs SMA 50
-60.1%
Price vs SMA 200
—
Avg volume (3M)
3.60M
Relative volume
0.0
Average dollar volume
$32.14M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
1.82M

Valuation

12 metrics
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 3,327.6%
PEG ratio
—
EV / revenue
0.2×
reciprocal yield 565.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 164.1%
P / book
0.9
reciprocal yield 116.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-457.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
38.4×
reciprocal yield 2.6%
EV / revenue historical average (5Y)
38.4×
reciprocal yield 2.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2023-05-15

Profitability

9 metrics
Gross margin
—
Operating margin
-246.1%
Trailing 12 months
Net margin
-278.9%
Gross profit (TTM)
$245,289
Operating profit (TTM)
−$13.60M
Net income (TTM)
−$15.41M
Trailing 12 months
Diluted EPS (TTM)
$61.56
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$24.27

Growth

11 metrics
Revenue growth YoY
-26.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$5.53M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1,160.8%
Year over year · more shares
Revenue CAGR (3Y)
-3.7%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-393.7%
Return on assets
-204.0%
Debt / equity
0.0
Current ratio
1.5
EBITDA (TTM)
−$13.23M
Free cash flow (TTM)
—
Quick ratio
1.5
Interest coverage
-270.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$2.39M
Latest balance sheet
Cash & equivalents
$2.55M
Total assets
$7.55M
Total debt
$160,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$12.86M
Capital expenditures (TTM)
$172,684
R&D (TTM)
$1.47M
SG&A (TTM)
$11.90M
Stock compensation (TTM)
$1.00M
R&D / revenue
26.7%
Stock compensation / revenue
18.2%

Ownership (13F)

9 metrics
13F filers
14
13F filer change QoQ
-7
Institutional ownership
16.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
28.0%
Private-fund adviser ownership
0.0%
Active holders' share change QoQ
+1,351.1%
Holder tenure
2.1
Price vs estimated holder cost
-78.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.4%

Short interest

3 metrics
Short interest
2.9%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
36 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1712762 CUSIP 09076W406 13F (30d) 21 filings 14 filers Visit website Investor relations